CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | ZANTE GREG Chief Financial Officer | Grant or award | +90,667 | 229,698 | ||
| 2023-01-03 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −23,933 | $8.52 | $204K | 205,765 |
| 2023-01-03 | ZANTE GREG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +204,000 | 204,000 | ||
| 2023-01-03 | Mancini Marianna Chief Operating Officer | Grant or award | +90,667 | 351,200 | ||
| 2023-01-03 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −18,854 | $8.52 | $161K | 332,346 |
| 2023-01-03 | Mancini Marianna Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +204,000 | 204,000 | ||
| 2023-01-03 | Lian Brian President & CEO | Grant or award | +266,667 | 2,369,834 | ||
| 2023-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −68,252 | $8.52 | $582K | 2,301,582 |
| 2023-01-03 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2023-01-03 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-01-03 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-01-03 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-01-03 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-01-03 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-12-30 | ZANTE GREG Chief Financial Officer | Grant or award | +20,233 | 158,728 | ||
| 2022-12-30 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −19,697 | $9.40 | $185K | 139,031 |
| 2022-12-30 | Mancini Marianna Chief Operating Officer | Grant or award | +23,500 | 273,306 | ||
| 2022-12-30 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −12,773 | $9.40 | $120K | 260,533 |
| 2022-12-30 | Lian Brian President & CEO | Grant or award | +121,667 | 2,169,294 | ||
| 2022-12-30 | Lian Brian President & CEO | Shares withheld for taxes | −66,127 | $9.40 | $622K | 2,103,167 |
Page 18 of 27 · 528 trades